DAVPX
Price
$34.72
Change
-$0.55 (-1.56%)
Updated
Sep 6 closing price
GFACX
Price
$61.91
Change
-$1.33 (-2.10%)
Updated
Sep 6 closing price
Ad is loading...

DAVPX vs GFACX

Header iconDAVPX vs GFACX Comparison
Open Charts DAVPX vs GFACXBanner chart's image
Davenport Core Leaders Fund
Price$34.72
Change-$0.55 (-1.56%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$61.91
Change-$1.33 (-2.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DAVPX vs GFACX Comparison Chart
Loading...
VS
DAVPX vs. GFACX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAVPX is a Buy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 270B vs. DAVPX (1.02B). DAVPX pays higher dividends than GFACX: DAVPX (0.28) vs GFACX (0.00). DAVPX was incepted earlier than GFACX: DAVPX (27 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. DAVPX (19.00). GFACX has a lower initial minimum investment than DAVPX: GFACX (250) vs DAVPX (5000). DAVPX annual gain was more profitable for investors over the last year : 18.70 vs. GFACX (16.44). GFACX (38.56) and DAVPX (38.22) have equivalent 5 years return.
DAVPXGFACXDAVPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD11.75814.98278%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B270B0%
Annual Yield % from dividends0.280.00-
Returns for 1 year18.7016.44114%
Returns for 3 years1.89-11.08-17%
Returns for 5 years38.2238.5699%
Returns for 10 years89.2842.46210%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KW11.040.03
+0.27%
Kennedy-Wilson Holdings
CTVA55.11-0.39
-0.70%
Corteva
FIVN29.58-0.24
-0.80%
Five9
VEV0.14N/A
-1.68%
Vicinity Motor Corp
ADAP1.11-0.05
-4.31%
Adaptimmune Therapeutics plc